1st Oct 2024 09:45
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 1 October 2024
Name of applicant: | Hikma Pharmaceuticals PLC | ||
Name of scheme: | Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans") | ||
Period of return | From: 1 April 2024 | To: | 30 September 2024 |
Balance of unallotted securities under scheme(s) from previous return: | The Plans: 312,624 Ordinary Shares of 10 pence | ||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | The Plans: 0 Ordinary Shares of 10 pence | ||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | MIP: 1,194 Ordinary Shares of 10 pence EIP: 0 Ordinary Shares of 10 pence | ||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | The Plans: 311,430 Ordinary Shares of 10 pence |
Name of contact: | Helen Middlemist |
Telephone number of contact: | +44(0)20 7399 2760 |
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)
(LEI: 549300BNS685UXH4JI75)
Related Shares:
Hikma Pharmaceuticals